Cargando…

Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant Chemotherapy

Background: Triple-negative breast cancer (TNBC) is characterized by a more aggressive biological behavior and unfavorable outcome. Circulating and histological expression of THBS2 has been demonstrated to be a novel diagnostic and prognostic biomarker in patients with various types of tumors. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yuxiang, Lin, E., Li, Yan, Chen, Xiaobin, Chen, Minyan, Huang, Jun, Guo, Wenhui, Chen, Lili, Wu, Long, Zhang, Xiang, Zhang, Wenzhe, Jin, Xuan, Zhang, Jie, Fu, Fangmeng, Wang, Chuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pathology and Oncology Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673122/ https://www.ncbi.nlm.nih.gov/pubmed/36405394 http://dx.doi.org/10.3389/pore.2022.1610559

Ejemplares similares

CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1
por: Lin, Yuxiang, et al.
Publicado: (2022)

In Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy Systemic Inflammation Response Index is a Useful Prognostic Indicator
por: Chen, Li, et al.
Publicado: (2021)

YTHDF3 facilitates triple-negative breast cancer progression and metastasis by stabilizing ZEB1 mRNA in an m(6)A-dependent manner
por: Lin, Yuxiang, et al.
Publicado: (2022)

Predictive role of neostromal CD10 expression in breast cancer patients treated with neoadjuvant chemotherapy
por: Olah, Orsolya, et al.
Publicado: (2023)

LncRNA PCIR Is an Oncogenic Driver via Strengthen the Binding of TAB3 and PABPC4 in Triple Negative Breast Cancer
por: Guo, Wenhui, et al.
Publicado: (2021)

Immunohistochemistry-based molecular subtyping of triple-negative breast cancer and its prognostic significance
por: Leeha, Marisa, et al.
Publicado: (2023)

Pretreatment Systemic Immune-Inflammation Index Can Predict Response to Neoadjuvant Chemotherapy in Cervical Cancer at Stages IB2-IIB
por: Liu, Pingping, et al.
Publicado: (2022)

Stat3 Tyrosine 705 and Serine 727 Phosphorylation Associate With Clinicopathological Characteristics and Distinct Tumor Cell Phenotypes in Triple-Negative Breast Cancer
por: Stenckova, Michaela, et al.
Publicado: (2022)

Impact of body mass index in therapeutic response for HER2 positive breast cancer treated with neoadjuvant targeted therapy: a multi-center study and meta-analysis
por: Chen, Lili, et al.
Publicado: (2023)

Quantification of Ki67 Change as a Valid Prognostic Indicator of Luminal B Type Breast Cancer After Neoadjuvant Therapy
por: Tan, Shirong, et al.
Publicado: (2021)

Integrative Analysis of DNA Methylation and Gene Expression Profiles Identifies Colorectal Cancer-Related Diagnostic Biomarkers
por: Xu, Mingyue, et al.
Publicado: (2021)

Genomic Landscape of Metastatic Lymph Nodes and Primary Tumors in Non-Small-Cell Lung Cancer
por: Chen, Bing, et al.
Publicado: (2022)

HER2 copy number quantification in primary tumor and cell-free DNA provides additional prognostic information in HER2 positive early breast cancer
por: Chen, Xiaobin, et al.
Publicado: (2022)

Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor–Positive Human Epidermal Growth Factor Receptor-2–Negative Early Breast Cancer Without Chemotherapy
por: Fu, Fangmeng, et al.
Publicado: (2022)

A Comprehensive Bioinformatic Analysis for Identification of Myeloid-Associated Differentiation Marker as a Potential Negative Prognostic Biomarker in Non-Small-Cell Lung Cancer
por: Zhou, Min, et al.
Publicado: (2022)

Low-grade oncocytic tumour (LOT) of the kidney is characterised by GATA3 positivity, FOXI1 negativity and mTOR pathway mutations
por: Chen, Tongbing, et al.
Publicado: (2023)

Clinical benefits of oral capecitabine over intravenous 5-fluorouracyl regimen in case of neoadjuvant chemoradiotherapy followed by surgery for locally advanced rectal cancer
por: Paszt, Attila, et al.
Publicado: (2022)

Influence of the microbiota on the effectiveness and toxicity of oncological therapies, with a focus on chemotherapy
por: Cazzaniga, Massimiliano, et al.
Publicado: (2023)

Cytokine-induced killer cell treatment is superior to chemotherapy alone in esophageal cancer
por: Sun, Jiayang, et al.
Publicado: (2023)

MET gene alterations predict poor survival following chemotherapy in patients with advanced cancer
por: Ko, Jihoon, et al.
Publicado: (2022)

Prognostic Value of Glasgow Prognostic Score in Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Zhang, Chuan-Long, et al.
Publicado: (2022)

Construction of a Metabolism-Related Long Non-Coding RNAs-Based Risk Score Model of Hepatocellular Carcinoma for Prognosis and Personalized Treatment Prediction
por: Zhang, Peichen, et al.
Publicado: (2022)

A Nomogram to Predict Disease-Free Survival Following Neoadjuvant Chemotherapy for Triple Negative Breast Cancer
por: Zhu, Meizhen, et al.
Publicado: (2021)

Emerging roles of the HECT E3 ubiquitin ligases in gastric cancer
por: Sun, Aiqin, et al.
Publicado: (2023)

Identification of an Oxidative Stress-Related LncRNA Signature for Predicting Prognosis and Chemotherapy in Patients With Hepatocellular Carcinoma
por: Zhong, Zixuan, et al.
Publicado: (2022)

Expression of SASP, DNA Damage Response, and Cell Proliferation Factors in Early Gastric Neoplastic Lesions: Correlations and Clinical Significance
por: Liang, Li, et al.
Publicado: (2022)

Identification of Co-Expression Modules and Genes Associated With Tumor Progression in Oral Squamous Cell Carcinoma
por: Fang, Zhijie, et al.
Publicado: (2022)

Clinicopathological Features and Survival of Signet-Ring Cell Carcinoma and Mucinous Adenocarcinoma of Right Colon, Left Colon, and Rectum
por: Zhu, Lili, et al.
Publicado: (2021)

Molecular Landscape of ERBB2 Alterations in 14,956 Solid Tumors
por: Wang, Hao, et al.
Publicado: (2022)

Expression of aquaporin 1, 3 and 5 in colorectal carcinoma: correlation with clinicopathological characteristics and prognosis
por: Zhang, Guangwen, et al.
Publicado: (2023)

IL-33 Participates in the Development of Esophageal Adenocarcinoma
por: Liu, Jia, et al.
Publicado: (2022)

CircRNA: A new class of targets for gastric cancer drug resistance therapy
por: Zheng, Ying, et al.
Publicado: (2023)

Identification and Characterization of Genes Related to the Prognosis of Hepatocellular Carcinoma Based on Single-Cell Sequencing
por: Chen, Wenbiao, et al.
Publicado: (2022)

Negative correlation between the nuclear size and nuclear Lamina component Lamin A in intraductal papillary mucinous neoplasms of the pancreas
por: Hiroe, Tamaki, et al.
Publicado: (2022)

The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy
por: Yang, Hui, et al.
Publicado: (2021)

Alterations of the Gut Microbiome in Patients With Pituitary Adenoma
por: Hu, Jinxian, et al.
Publicado: (2022)

New staging systems for left-sided colon cancer based on the number of retrieved and metastatic lymph nodes provide a more accurate prognosis
por: Jia, Guiru, et al.
Publicado: (2023)

Efficacy of the low dose apatinib plus deep hyperthermia as third-line or later treatment in HER-2 negative advanced gastric cancer
por: Han, Guohu, et al.
Publicado: (2023)

RCC1 Expression as a Prognostic Marker in Colorectal Liver Oligometastases
por: Deng, Yuxiang, et al.
Publicado: (2021)

Vasculogenic Mimicry Formation Predicts Tumor Progression in Oligodendroglioma
por: Xie, Jing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a68u09f5ps8lan9vjnt6v3mjgn